Literature DB >> 9275016

Sensitization to locomotor effects of methylphenidate in the rat.

O Gaytan1, S al-Rahim, A Swann, N Dafny.   

Abstract

A computerized activity monitoring system was used to investigate whether repeated exposure to methylphenidate (MPD) could produce sensitization to its locomotor effects in the rat. Male Sprague-Dawley rats were housed in test cages and activity was recorded continuously for 16 days as follows: Baseline activity (Day 1-2), recording following saline injection (Day 3), MPD Challenge Doses--either 0.6, 2.5, or 10 mg/kg of MPD (Day 4); five days of a repeated dose of 2.5 mg/kg (Day 5-9), five additional recording days of no treatment (Days 10-14), and MPD Re-Challenge (Day 15). Each group was re-challenged with the same doses as on day 4. Recording was resumed for an additional post-treatment day (Day 16). All injections were at 14:00. Horizontal activity, total distance, vertical activity, stereotypic activity, and number of stereotypic movements were recorded and analyzed. An augmented response (i.e., sensitization) was observed only to the lower MPD doses of 0.6 and 2.5 mg/kg. The sensitized response was more pronounced for forward ambulation than for rearing, with a complete lack of sensitization to the stereotypic effects of MPD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9275016     DOI: 10.1016/s0024-3205(97)00598-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  33 in total

1.  Adolescent rat circadian activity is modulated by psychostimulants.

Authors:  M Bergheim; P B Yang; K D Burau; N Dafny
Journal:  Brain Res       Date:  2011-10-19       Impact factor: 3.252

2.  Repetitive methylphenidate administration modulates the diurnal behavioral activity pattern of adult female SD rats.

Authors:  Min J Lee; Pamela B Yang; Victor T Wilcox; Keith D Burau; Alan C Swann; Nachum Dafny
Journal:  J Neural Transm (Vienna)       Date:  2010-11-06       Impact factor: 3.575

3.  Acute and chronic methylphenidate alters prefrontal cortex neuronal activity recorded from freely behaving rats.

Authors:  R Layla Salek; Catherine M Claussen; Adriana Pérez; Nachum Dafny
Journal:  Eur J Pharmacol       Date:  2012-01-25       Impact factor: 4.432

4.  Behavioral and neuronal recording of the nucleus accumbens in adolescent rats following acute and repetitive exposure to methylphenidate.

Authors:  Alexander Frolov; Cruz Reyes-Vasquez; Nachum Dafny
Journal:  J Neurophysiol       Date:  2014-10-15       Impact factor: 2.714

5.  Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains.

Authors:  Pamela B Yang; Alan C Swann; Nachum Dafny
Journal:  Brain Res Bull       Date:  2006-10-19       Impact factor: 4.077

6.  Glutaminergic signaling in the caudate nucleus is required for behavioral sensitization to methylphenidate.

Authors:  Nicholas King; Samuel Floren; Natasha Kharas; Ming Thomas; Nachum Dafny
Journal:  Pharmacol Biochem Behav       Date:  2019-06-19       Impact factor: 3.533

7.  Nucleus accumbens lesions modulate the effects of methylphenidate.

Authors:  Adam Podet; Min J Lee; Alan C Swann; Nachum Dafny
Journal:  Brain Res Bull       Date:  2010-05-12       Impact factor: 4.077

Review 8.  Methylphenidate and the juvenile brain: enhancement of attention at the expense of cortical plasticity?

Authors:  Kimberly R Urban; Wen-Jun Gao
Journal:  Med Hypotheses       Date:  2013-09-17       Impact factor: 1.538

9.  Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine.

Authors:  Ronald Kuczenski; David S Segal
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

10.  Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate.

Authors:  S J Wanchoo; M J Lee; A C Swann; N Dafny
Journal:  Brain Res       Date:  2009-11-22       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.